Two characteristic features of malignant gliomas (MG) are the presence of hypoxia and accumulation of regulatory T cells (Tregs). Heme-oxygenase-1 (HO1) is a cytoprotective enzyme expressed in high level by Tregs in glioma. In this study, we show that higher HO1 expression in Tregs is associated with increased survival under hypoxic conditions and that HO1 inhibitor, tin protoporphyrin (SnPP), abrogates the survival benefits. Moreover, SnPP preferentially eliminates Tregs and treatment with SnPP of tumor bearing mice significantly increases survival (23 to 31 days (p b 0.05)). Thus HO1 inhibition provides another alternative way of therapeutically targeting Tregs in MG.
Introduction

CD4 +
CD25
+ T cells play a critical role in suppression of autoimmunity and are known as regulatory T cells (Tregs) (Sakaguchi et al., 1995) . Our group, and several others, have independently shown that this subset of highly suppressive T cells plays a pathological role in brain tumor progression (El Andaloussi et al., 2006; Fecci et al., 2006; Wainwright et al., 2013) . Malignant gliomas (MG), consisting of anaplastic astrocytoma and glioblastoma multiforme, are associated with a potently immunosuppressive tumor microenvironment and efficiently evade the host anti-tumor response. One of the major players in the induction and/or maintenance of immunosuppression in MG are the infiltration and accumulation of Tregs both peripherally and within the tumor itself (El Andaloussi et al., 2006; El Andaloussi and Lesniak, 2007; James, 2011; Crane et al., 2012) . Previously, we demonstrated that brain tumor-infiltrating Tregs are predominantly thymus-derived natural Tregs (nTregs) that constitutively express high levels of the receptor, glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) (Shimizu et al., 2002; Wainwright et al., 2011) . Tregs suppress the function(s) of antigen presenting cells (APC) via the expression of immunosuppressive cytokines, such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β) and inhibit the function of effector T cells by cytokine-and contact dependent-mechanisms (Larmonier et al., 2007; Corthay, 2009) . Although chemokines have been suggested to be critical in recruiting Tregs to brain tumors, several other factors involving tumor-associated cellular hypoxia and tumorexpressed indoleamine 2,3-dioxygenase have also been shown to regulate Treg recruitment and/or expansion (Fang et al., 2003; Facciabene et al., 2011; Wainwright et al., 2012) . However, the factors that promote Treg survival in the tumor microenvironment have yet to be defined in vivo. Heme oxygenase-1 (HO1) is a stress-responsive cytoprotective enzyme that degrades free heme to carbon monoxide (CO) and iron, which is further converted to ferritin (an iron-sequestering protein) and biliverdin, which is converted to bilirubin (Lee and Chau, 2002) . Expression of HO1 is regulated at the transcriptional level, with some notable exceptions including mRNA stabilization by hypoxia or acidosis (Gozzelino et al., 2010) . The protective role of HO1 during periods of cellular stress induced by hypoxia, reactive oxygen species and/or acidosis has been previously established and characterized (Gozzelino et al., 2010) . Coincidently, our group previously showed that Tregs have high expression of HO1 and that the frequencies of HO1 and Tregs simultaneously increase with the grade of astrocytoma (El Andaloussi and Lesniak, 2007) . Although there are studies demonstrating that Treg development, maintenance and function are independent of HO1 activity under physiological conditions in mice (Zelenay et al., 2007) , the role of HO1 in Tregs has yet to be investigated in the context of a brain tumor.
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